Dravet Syndrome clinical trials at UCSD
1 research study open to eligible people
open to eligible people ages 2 years and up
The primary purpose of the study is to demonstrate that lorcaserin has superior efficacy compared to placebo on percent change in frequency of convulsive seizures per 28 days in participants with Dravet syndrome.
San Diego, California and other locations